SIRT1-dependent effects of resveratrol and grape juice in an in vitro model of preeclampsia
Autor(a) principal: | |
---|---|
Data de Publicação: | 2020 |
Outros Autores: | , , , , , |
Tipo de documento: | Artigo |
Idioma: | eng |
Título da fonte: | Repositório Institucional da UNESP |
Texto Completo: | http://dx.doi.org/10.1016/j.biopha.2020.110659 http://hdl.handle.net/11449/200957 |
Resumo: | Preeclampsia (PE) is a multifactorial hypertensive disorder of pregnancy that is partly responsible for both maternal and fetal morbidity and mortality levels worldwide. It has been recently discovered that sirtuin-1 (SIRT1) is reduced in the circulation and in an in vitro model of PE. Therefore, in this study, we investigated the effects of trans-resveratrol, a potent antioxidant and activator of SIRT1, on oxidative stress and nitric oxide (NO) production in an in vitro model of PE compared to gestational hypertensive (GH) and healthy pregnant (HP) women. Furthermore, we also evaluated the effects of an acute intake of grape juice on women with PE to assess whether it could mimic in vitro trans-resveratrol supplementation. (1) In the GH group, resveratrol decreased intracellular reactive oxygen species (ROS) and increased their antioxidant capacity, while inhibiting SIRT1 reestablished previous levels. (2) In PE, inhibition of SIRT1 increased antioxidant activity. (3) Intracellular NO and supernatant nitrite levels were increased by inhibiting SIRT1 in the PE group. (4) Grape juice intake increased intracellular NO levels versus before grape juice intake control; however, the inhibition of SIRT1 before grape juice intake initially increased NO, but decreased it 1 h after grape juice intake. In conclusion, activating SIRT1 by using resveratrol alone may not be beneficial to women with PE, and GH and PE seem to have different responsive mechanisms to this molecule. Furthermore, grape juice intake seems to have different effects compared to resveratrol supplementation alone in this in vitro model of PE, demonstrating the potential of the combination of other biologically active molecules from grape juice over the SIRT1-eNOS-NO in PE treatment. |
id |
UNSP_9796f9cd0202bf3b3bd867819bb136d8 |
---|---|
oai_identifier_str |
oai:repositorio.unesp.br:11449/200957 |
network_acronym_str |
UNSP |
network_name_str |
Repositório Institucional da UNESP |
repository_id_str |
2946 |
spelling |
SIRT1-dependent effects of resveratrol and grape juice in an in vitro model of preeclampsiaEndotheliumGrape juiceNitric oxideOxidative stressPreeclampsiaResveratrolSIRT1Preeclampsia (PE) is a multifactorial hypertensive disorder of pregnancy that is partly responsible for both maternal and fetal morbidity and mortality levels worldwide. It has been recently discovered that sirtuin-1 (SIRT1) is reduced in the circulation and in an in vitro model of PE. Therefore, in this study, we investigated the effects of trans-resveratrol, a potent antioxidant and activator of SIRT1, on oxidative stress and nitric oxide (NO) production in an in vitro model of PE compared to gestational hypertensive (GH) and healthy pregnant (HP) women. Furthermore, we also evaluated the effects of an acute intake of grape juice on women with PE to assess whether it could mimic in vitro trans-resveratrol supplementation. (1) In the GH group, resveratrol decreased intracellular reactive oxygen species (ROS) and increased their antioxidant capacity, while inhibiting SIRT1 reestablished previous levels. (2) In PE, inhibition of SIRT1 increased antioxidant activity. (3) Intracellular NO and supernatant nitrite levels were increased by inhibiting SIRT1 in the PE group. (4) Grape juice intake increased intracellular NO levels versus before grape juice intake control; however, the inhibition of SIRT1 before grape juice intake initially increased NO, but decreased it 1 h after grape juice intake. In conclusion, activating SIRT1 by using resveratrol alone may not be beneficial to women with PE, and GH and PE seem to have different responsive mechanisms to this molecule. Furthermore, grape juice intake seems to have different effects compared to resveratrol supplementation alone in this in vitro model of PE, demonstrating the potential of the combination of other biologically active molecules from grape juice over the SIRT1-eNOS-NO in PE treatment.Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq)Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP)Department of Biophysics and Pharmacology Institute of Biosciences of Botucatu Universidade Estadual Paulista (UNESP) Distrito Rubiao Junior BotucatuDepartment of Gynecology and Obstetrics Faculty of Medicine of Ribeirao Preto University of Sao Paulo Ribeirao PretoDepartment of Biophysics and Pharmacology Institute of Biosciences of Botucatu Universidade Estadual Paulista (UNESP) Distrito Rubiao Junior BotucatuCNPq: 2014-5/305587FAPESP: 2015/20461-8FAPESP: 2019/06118-0FAPESP: 2019/07230-8CNPq: 301293/2018-0Universidade Estadual Paulista (Unesp)Universidade de São Paulo (USP)Viana-Mattioli, Sarah [UNESP]Cinegaglia, Naiara [UNESP]Bertozzi-Matheus, Mariana [UNESP]Bueno-Pereira, Thaina Omia [UNESP]Caldeira-Dias, Mayara [UNESP]Cavalli, Ricardo CarvalhoSandrim, Valeria Cristina [UNESP]2020-12-12T02:20:29Z2020-12-12T02:20:29Z2020-11-01info:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articlehttp://dx.doi.org/10.1016/j.biopha.2020.110659Biomedicine and Pharmacotherapy, v. 131.1950-60070753-3322http://hdl.handle.net/11449/20095710.1016/j.biopha.2020.1106592-s2.0-85089886956Scopusreponame:Repositório Institucional da UNESPinstname:Universidade Estadual Paulista (UNESP)instacron:UNESPengBiomedicine and Pharmacotherapyinfo:eu-repo/semantics/openAccess2021-10-23T15:41:17Zoai:repositorio.unesp.br:11449/200957Repositório InstitucionalPUBhttp://repositorio.unesp.br/oai/requestopendoar:29462024-08-05T18:06:18.797736Repositório Institucional da UNESP - Universidade Estadual Paulista (UNESP)false |
dc.title.none.fl_str_mv |
SIRT1-dependent effects of resveratrol and grape juice in an in vitro model of preeclampsia |
title |
SIRT1-dependent effects of resveratrol and grape juice in an in vitro model of preeclampsia |
spellingShingle |
SIRT1-dependent effects of resveratrol and grape juice in an in vitro model of preeclampsia Viana-Mattioli, Sarah [UNESP] Endothelium Grape juice Nitric oxide Oxidative stress Preeclampsia Resveratrol SIRT1 |
title_short |
SIRT1-dependent effects of resveratrol and grape juice in an in vitro model of preeclampsia |
title_full |
SIRT1-dependent effects of resveratrol and grape juice in an in vitro model of preeclampsia |
title_fullStr |
SIRT1-dependent effects of resveratrol and grape juice in an in vitro model of preeclampsia |
title_full_unstemmed |
SIRT1-dependent effects of resveratrol and grape juice in an in vitro model of preeclampsia |
title_sort |
SIRT1-dependent effects of resveratrol and grape juice in an in vitro model of preeclampsia |
author |
Viana-Mattioli, Sarah [UNESP] |
author_facet |
Viana-Mattioli, Sarah [UNESP] Cinegaglia, Naiara [UNESP] Bertozzi-Matheus, Mariana [UNESP] Bueno-Pereira, Thaina Omia [UNESP] Caldeira-Dias, Mayara [UNESP] Cavalli, Ricardo Carvalho Sandrim, Valeria Cristina [UNESP] |
author_role |
author |
author2 |
Cinegaglia, Naiara [UNESP] Bertozzi-Matheus, Mariana [UNESP] Bueno-Pereira, Thaina Omia [UNESP] Caldeira-Dias, Mayara [UNESP] Cavalli, Ricardo Carvalho Sandrim, Valeria Cristina [UNESP] |
author2_role |
author author author author author author |
dc.contributor.none.fl_str_mv |
Universidade Estadual Paulista (Unesp) Universidade de São Paulo (USP) |
dc.contributor.author.fl_str_mv |
Viana-Mattioli, Sarah [UNESP] Cinegaglia, Naiara [UNESP] Bertozzi-Matheus, Mariana [UNESP] Bueno-Pereira, Thaina Omia [UNESP] Caldeira-Dias, Mayara [UNESP] Cavalli, Ricardo Carvalho Sandrim, Valeria Cristina [UNESP] |
dc.subject.por.fl_str_mv |
Endothelium Grape juice Nitric oxide Oxidative stress Preeclampsia Resveratrol SIRT1 |
topic |
Endothelium Grape juice Nitric oxide Oxidative stress Preeclampsia Resveratrol SIRT1 |
description |
Preeclampsia (PE) is a multifactorial hypertensive disorder of pregnancy that is partly responsible for both maternal and fetal morbidity and mortality levels worldwide. It has been recently discovered that sirtuin-1 (SIRT1) is reduced in the circulation and in an in vitro model of PE. Therefore, in this study, we investigated the effects of trans-resveratrol, a potent antioxidant and activator of SIRT1, on oxidative stress and nitric oxide (NO) production in an in vitro model of PE compared to gestational hypertensive (GH) and healthy pregnant (HP) women. Furthermore, we also evaluated the effects of an acute intake of grape juice on women with PE to assess whether it could mimic in vitro trans-resveratrol supplementation. (1) In the GH group, resveratrol decreased intracellular reactive oxygen species (ROS) and increased their antioxidant capacity, while inhibiting SIRT1 reestablished previous levels. (2) In PE, inhibition of SIRT1 increased antioxidant activity. (3) Intracellular NO and supernatant nitrite levels were increased by inhibiting SIRT1 in the PE group. (4) Grape juice intake increased intracellular NO levels versus before grape juice intake control; however, the inhibition of SIRT1 before grape juice intake initially increased NO, but decreased it 1 h after grape juice intake. In conclusion, activating SIRT1 by using resveratrol alone may not be beneficial to women with PE, and GH and PE seem to have different responsive mechanisms to this molecule. Furthermore, grape juice intake seems to have different effects compared to resveratrol supplementation alone in this in vitro model of PE, demonstrating the potential of the combination of other biologically active molecules from grape juice over the SIRT1-eNOS-NO in PE treatment. |
publishDate |
2020 |
dc.date.none.fl_str_mv |
2020-12-12T02:20:29Z 2020-12-12T02:20:29Z 2020-11-01 |
dc.type.status.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
http://dx.doi.org/10.1016/j.biopha.2020.110659 Biomedicine and Pharmacotherapy, v. 131. 1950-6007 0753-3322 http://hdl.handle.net/11449/200957 10.1016/j.biopha.2020.110659 2-s2.0-85089886956 |
url |
http://dx.doi.org/10.1016/j.biopha.2020.110659 http://hdl.handle.net/11449/200957 |
identifier_str_mv |
Biomedicine and Pharmacotherapy, v. 131. 1950-6007 0753-3322 10.1016/j.biopha.2020.110659 2-s2.0-85089886956 |
dc.language.iso.fl_str_mv |
eng |
language |
eng |
dc.relation.none.fl_str_mv |
Biomedicine and Pharmacotherapy |
dc.rights.driver.fl_str_mv |
info:eu-repo/semantics/openAccess |
eu_rights_str_mv |
openAccess |
dc.source.none.fl_str_mv |
Scopus reponame:Repositório Institucional da UNESP instname:Universidade Estadual Paulista (UNESP) instacron:UNESP |
instname_str |
Universidade Estadual Paulista (UNESP) |
instacron_str |
UNESP |
institution |
UNESP |
reponame_str |
Repositório Institucional da UNESP |
collection |
Repositório Institucional da UNESP |
repository.name.fl_str_mv |
Repositório Institucional da UNESP - Universidade Estadual Paulista (UNESP) |
repository.mail.fl_str_mv |
|
_version_ |
1808128894959616000 |